Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Schiff

Showing results (141-150 of 305) with videos related to

Pageof 31
Sort By:
World Neurosurgery|March 13, 2016
Redefining the Prevalence of Dural Involvement in Rosai-Dorfman Disease of the Central Nervous SystemChristopher S Hong, Robert M Starke, Michael A Hays, et al.
Medical Hypotheses|May 7, 2013
The p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes virusesAlexander V Kofman, Christopher Letson, Evan Dupart, et al.
Journal of Neuro-Oncology|September 25, 2019
Oligodendroglioma confers higher risk of radiation necrosisHaroon Ahmad, David Martin, Sohil H Patel, et al.
Journal of Neurosurgery|January 18, 2011
Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomasJonathan H Sherman, Krisztina Moldovan, H Kwang Yeoh, et al.
Neoplasia (New York, N.Y.)|August 3, 2013
A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapyXiaoping Huang, Ying Zhang, Yaqiong Tang, et al.
Journal of Neuro-Oncology|September 19, 2019
Increased intratumoral infiltration in IDH wild-type lower-grade gliomas observed with diffusion tensor imagingEric Aliotta, Prem P Batchala, David Schiff, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 4, 2018
Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case reportDavis G Taylor, Adeel Ilyas, Gautam U Mehta, et al.
Cancer|November 21, 2015
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomasDavid Schiff, Annick Desjardins, Timothy Cloughesy, et al.
Molecular Cancer Therapeutics|December 23, 2011
Cooperation between c-Met and focal adhesion kinase family members in medulloblastoma and implications for therapyFadila Guessous, Yanzhi Yang, Elizabeth Johnson, et al.
Cancer Research|January 16, 2014
microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastomaJungeun Kim, Ying Zhang, Michael Skalski, et al.
Pageof 31

Showing results (141-150 of 305) with videos related to

Sort By:
Pageof 31
World Neurosurgery|March 13, 2016
Redefining the Prevalence of Dural Involvement in Rosai-Dorfman Disease of the Central Nervous SystemChristopher S Hong, Robert M Starke, Michael A Hays, et al.
Medical Hypotheses|May 7, 2013
The p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes virusesAlexander V Kofman, Christopher Letson, Evan Dupart, et al.
Journal of Neuro-Oncology|September 25, 2019
Oligodendroglioma confers higher risk of radiation necrosisHaroon Ahmad, David Martin, Sohil H Patel, et al.
Journal of Neurosurgery|January 18, 2011
Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomasJonathan H Sherman, Krisztina Moldovan, H Kwang Yeoh, et al.
Neoplasia (New York, N.Y.)|August 3, 2013
A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapyXiaoping Huang, Ying Zhang, Yaqiong Tang, et al.
Journal of Neuro-Oncology|September 19, 2019
Increased intratumoral infiltration in IDH wild-type lower-grade gliomas observed with diffusion tensor imagingEric Aliotta, Prem P Batchala, David Schiff, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 4, 2018
Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case reportDavis G Taylor, Adeel Ilyas, Gautam U Mehta, et al.
Cancer|November 21, 2015
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomasDavid Schiff, Annick Desjardins, Timothy Cloughesy, et al.
Molecular Cancer Therapeutics|December 23, 2011
Cooperation between c-Met and focal adhesion kinase family members in medulloblastoma and implications for therapyFadila Guessous, Yanzhi Yang, Elizabeth Johnson, et al.
Cancer Research|January 16, 2014
microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastomaJungeun Kim, Ying Zhang, Michael Skalski, et al.
Pageof 31